Accelerating next gen sequencing & diagnostics
Los Angeles, CA, USA
MWV, Embark, InAmerica
Chris Angermayer, Co-Founder & CEO
SeqOnce is accelerating life science discoveries and improving patient outcomes by focusing on Next Gen Sequencing for genomics and diagnostics. SeqOnce’s proprietary technology uses a unique set of enzymatic reactions to reduce reaction steps and reagents. The result is a sample library prep kit that is fast, easy to use, and produces high-quality libraries regardless of sample source or application.